- Home
- NMTC vs GSIW Comparison
NMTC vs GSIW Comparison
Compare NMTC & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMTC | GSIW |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 28.6M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | NMTC | GSIW |
|---|---|---|
| Price | $0.79 | $0.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.23 | N/A |
| AVG Volume (30 Days) | 252.9K | ★ 342.2K |
| Earning Date | 12-17-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,097,692.00 | $5,368,221.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $31.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 250.35 | ★ 283.23 |
| 52 Week Low | $0.40 | $0.09 |
| 52 Week High | $1.39 | $1.79 |
Technical Indicators
Market Signals| Indicator | NMTC | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 38.36 |
| Support Level | $0.65 | $0.13 |
| Resistance Level | $0.83 | $0.15 |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 92.18 | 13.44 |
Price Performance
Historical ComparisonAbout NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.